lobbying_activities: 2139597

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2139597	550104f5-fad6-4271-872e-e28b06aeb8cb	2T	ACG ADVOCACY	2057	ROIVANT SCIENCES, INC.	2018	second_quarter	PHA	Drug Pricing. Innovation Issues.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	30000		0	1	2018-06-29T13:56:42.033000-04:00